Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 196.87MCurrent Assets
VS
Market
Sector
Industry
History
$ 16.95Close
$ 3.93 - $ 21.42 52-Week Range
Ticker Information
Ticker
URGNCompany Name
UROGEN PHARMA LTDSector
HealthcareIndustry
BiotechnologyExchange
NASDAQUROGEN PHARMA LTD - Current Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
URGN - AssetsC Historical data
| Date | Current Assets |
|---|---|
| 6/30/2025 | $ 196.87M |
| 3/31/2025 | $ 237.18M |
| 12/31/2024 | $ 276.13M |
| 9/30/2024 | $ 295.1M |
| 6/30/2024 | $ 278.97M |
| 3/31/2024 | $ 196.76M |
| 12/31/2023 | $ 169.19M |
| 9/30/2023 | $ 182.12M |
| 6/30/2023 | $ 81.33M |
| 3/31/2023 | $ 95.97M |
Key Performance Insights, Last 5 Years
- UROGEN PHARMA LTD's latest trailing twelve months (TTM) AssetsC stands at $ 129.34M.
- Over the past 5 years, UROGEN PHARMA LTD's average AssetsC has been $ 163.92M.
- The median AssetsC for UROGEN PHARMA LTD during this period was $ 140.06M
- UROGEN PHARMA LTD reached its highest AssetsC over the past 5 years at $ 295.1M.
- The lowest AssetsC recorded by UROGEN PHARMA LTD in the same timeframe $ 81.33M
UROGEN PHARMA LTD's AssetsC vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC Benchmarks
Similar metrics to AssetsC:
- Non-Current Assets - [Balance Sheet] The non-current (long-term) portion of [Assets] that are not easily converted to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
- Current Debt - [Balance Sheet] The current (short-term) portion of [Debt] includes the formal borrowings that are due within a year; reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
- Current Liabilities - [Balance Sheet] The current (short-term) portion of [Liabilities] includes obligations that are due to be paid to creditors within one year, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
- Non-Current Liabilities - [Balance Sheet] The non-current (long-term) portion of [Liabilities] includes obligations that are due to be paid to creditors more than year in the future, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
Definition of Current Assets
[Balance Sheet] The current (short-term) portion of [Assets] that are usually convertible to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.URGN - Current Assets, Last 5 years
$ 81.33M
Minimum
Jun 30, 2023
$ 295.1M
Maximum
Sep 30, 2024
$ 163.92M
Average
$ 140.06M
Median
AssetsC Benchmark AnalysisMarket
The chart above depicts the distribution of AssetsC for companies in the Total Stock Market. The average AssetsC of the companies is $ 325.11M with a standard deviation of $ 406.03M.
The following table provides additional summary stats:
AssetsC in the Market:
| filtered constituents | 2.9K |
|---|---|
| min | $ 0 |
| max | $ 1.66B |
| average | $ 325.11M |
| median | $ 147.87M |
| std | $ 406.03M |